MET SEC Filings

MetLife, Inc. (MET) has filed an 8-K report on February 17, 2026, primarily announcing the declaration of various preferred stock dividends. Investors should note the specific dividend amounts and frequencies for Series D, Series E, Series F, and Series A preferred stock. The declaration of these dividends indicates the company's ongoing commitment to returning capital to its shareholders, a positive sign for preferred stockholders.

MetLife, Inc. has filed an 8-K report on February 4, 2026, detailing its financial results for the quarter and full year ended December 31, 2025, and providing an outlook for 2026. The company's outlook acknowledges continued economic uncertainty regarding inflation and unemployment, while expecting a relatively stable U.S. dollar and a moderate rise in long-term interest rates with a steepening yield curve in 2026. MetLife highlights its robust capital position, maintaining $3.6 billion in holding company cash, within its target range, and reiterates its commitment to returning capital to shareholders, having returned approximately $4.4 billion in 2025 and remaining on track to generate $25.0 billion in free cash flow over the 2025-2029 period.

MetLife, Inc. (MET) has announced a significant organizational restructuring effective in the fourth quarter of 2025, aimed at accelerating growth in its asset management business. The key change involves elevating MetLife Investment Management (MIM) to a standalone reportable segment. Previously, MIM was housed within 'Corporate & Other'. This move is intended to provide greater visibility and focus on the company's institutional asset management capabilities. In conjunction with this, MetLife Holdings will no longer be a reportable segment and its results will primarily be integrated into 'Corporate & Other'. Additionally, certain product lines formerly within MetLife Holdings have been realigned into the Group Benefits and Retirement and Income Solutions (RIS) segments. These segment changes have been applied retrospectively to prior periods for enhanced comparability. The company also adjusted inter-company management fee agreements for MIM to reflect current market rates, a change also applied retrospectively. Importantly, these organizational and accounting adjustments did not impact prior consolidated net income or adjusted earnings.

MetLife, Inc. (MET) has filed an 8-K report on December 30, 2025, announcing the successful closing of its acquisition of PineBridge Investments, LLC and its affiliates by MetLife Investment Management. This strategic move significantly expands MetLife's investment management capabilities and assets under management. The company also released a pro forma fact sheet detailing the combined total assets under management (AUM) as if the acquisition had occurred on September 30, 2025. This information provides investors with a clear picture of the scale and potential impact of this significant transaction on MetLife's investment arm.

MetLife, Inc. has filed an 8-K report to provide investors with a preliminary update on its financial performance and outlook for the fiscal year ending December 31, 2025, ahead of its official earnings release. The company anticipates variable investment income for the fourth quarter of 2025 to be between $385 million and $435 million (pre-tax), slightly below its quarterly target of $425 million, but expects its full-year 2025 variable investment income to be around $1.7 billion (pre-tax). In terms of capital management, MetLife is prioritizing organic growth, with an estimated $4 billion deployed in 2025, and an additional $1 billion for M&A, including the pending acquisition of PineBridge Investments. The company also expects to repurchase approximately $2.85 billion of its common stock in 2025, a level it anticipates maintaining in 2026. Investors should note that this information is preliminary and unaudited, and actual results could materially differ.

MetLife, Inc. has announced the completion of a significant reinsurance transaction with Talcott Resolution Life Insurance Company. This transaction involves approximately $10 billion of U.S. retail variable annuity and rider reserves. The reinsurance agreement aims to reduce MetLife's exposure to certain legacy blocks of business, potentially improving capital efficiency and strategic focus. Investors should view this as a move to de-risk the balance sheet and free up capital for other strategic initiatives or shareholder returns.

MetLife, Inc. (MET) has filed an 8-K Current Report on November 17, 2025, primarily announcing the declaration of quarterly dividends on its preferred stock. This filing is important for preferred stockholders as it confirms the payment of regular dividends for Series A, Series E, and Series F preferred stock. Investors should note that these are dividend declarations, indicating the company's continued commitment to returning capital to its shareholders.

MetLife Inc. reported its third-quarter 2025 financial results, showing a decrease in net income available to common shareholders to $818 million, or $1.22 per diluted share, compared to $1.3 billion, or $1.81 per diluted share, in the same period of 2024. This decline was primarily attributed to unfavorable changes in net investment gains/losses and significant unfavorable changes in net derivative gains/losses, largely due to currency movements and interest rate fluctuations. Despite the decline in net income, adjusted earnings available to common shareholders remained relatively stable at $1.6 billion for the three months ended September 30, 2025, compared to $1.4 billion in the prior year's quarter. This resilience in adjusted earnings was driven by positive market factors such as higher private equity returns and recurring investment income, as well as volume growth across segments like Asia and Latin America. However, underwriting adjustments and expense management were areas that presented challenges. The company's total assets grew to $719.7 billion, with a continued focus on managing its investment portfolio and capital resources.

MetLife, Inc. has filed an 8-K report on November 5, 2025, primarily to furnish investors with their third-quarter 2025 financial results. The filing includes a news release detailing the earnings for the quarter ended September 30, 2025, a supplementary financial report, and a fact sheet on total assets under management (AUM) as of the same date. Additionally, a supplemental slide presentation has been provided, offering further insights into the company's performance and relevant prior disclosures. While this 8-K does not contain new material events or definitive financial statements in the traditional sense, it serves as a crucial communication channel for investors to access the latest operational and financial condition updates. Investors should review the accompanying exhibits, particularly the Earnings Release and Quarterly Financial Supplement, for specific details on revenue, profitability, AUM growth, and any management commentary on business performance and outlook.

MetLife Inc. (MET) has filed a Current Report (8-K) detailing the elimination of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G. This action, effective October 14, 2025, follows the complete redemption, repurchase, or reacquisition of all outstanding shares of this preferred stock. The filing with the Delaware Secretary of State formally removes the Series G Preferred Stock provisions from MetLife's Amended and Restated Certificate of Incorporation. From an investor's perspective, this filing indicates a simplification of MetLife's capital structure. The elimination of this specific series of preferred stock suggests the company has managed its outstanding liabilities and financial obligations effectively. While this event does not involve new financial performance metrics or strategic shifts, it represents a housekeeping item that tidies up the company's corporate governance and share structure, potentially reducing administrative complexity.

MetLife, Inc. (MET) has filed a Form 8-K to provide investors with preliminary insights into its estimated variable investment income for the quarter ending September 30, 2025. The company anticipates that this income will meet its quarterly target of $425 million (pre-tax). This figure is part of MetLife's full-year guidance of approximately $1.7 billion (pre-tax) for variable investment income, which includes returns from private equity, real estate, other funds, and prepayment fees. It is crucial for investors to understand that this information is preliminary, unaudited, and based on data available as of the filing date. MetLife has not completed its financial closing procedures for the quarter, and actual results may differ materially. Investors should exercise caution and avoid drawing conclusions about other financial or operating data not provided in this disclosure. This preliminary data should not be considered a substitute for the comprehensive financial statements prepared under U.S. GAAP or indicative of future performance.

MetLife, Inc. (MET) has filed an 8-K to disclose receipt of an unsolicited "mini-tender" offer from Potemkin Limited to purchase up to 10,000 shares of common stock at $53.00 per share. This offer price represents a significant discount of approximately 34.42% compared to the recent closing price of $80.82 on September 12, 2025. MetLife, Inc. explicitly states that it does not endorse this offer and is not affiliated with Potemkin Limited. The company is actively advising its shareholders to reject the offer and not tender their shares. The shares targeted by this offer represent a minuscule fraction of the company's outstanding stock, underscoring the limited impact this specific offer is likely to have on the overall shareholder base. Investors should exercise caution and carefully review the terms of any unsolicited offer.

MetLife, Inc. (MET) announced on September 2, 2025, via an 8-K filing, its intention to redeem all outstanding shares of its 3.850% fixed rate reset non-cumulative preferred stock, Series G. This redemption will occur on September 15, 2025, with each share being bought back at its liquidation preference of $1,000 per share. Investors holding Series G Preferred Stock should note that the final semi-annual dividend of $19.250 per share will be paid on the redemption date, September 15, 2025, to shareholders of record as of August 29, 2025. This dividend is separate from and not included in the $1,000 redemption price.

MetLife Inc. (MET) has filed an 8-K report detailing the declaration of various preferred stock dividends, as announced in a news release dated August 15, 2025. The report primarily serves to inform investors about the company's commitment to returning capital through regular dividend payments across its preferred stock series. Investors should note the different dividend frequencies (quarterly and semi-annual) and rates associated with each preferred stock series. These declarations are routine and reflect MetLife's ongoing financial management and capital allocation strategies, reinforcing its financial stability and dedication to preferred shareholders. The filing itself does not indicate any significant new business developments or changes in financial performance beyond these dividend announcements.

MetLife, Inc. (MET) reported its financial results for the period ending June 30, 2025. The company experienced a decrease in net income available to common shareholders to $698 million for the three months ended June 30, 2025, down from $912 million in the same period last year. Adjusted earnings available to common shareholders also saw a decline, coming in at $1.36 billion for the quarter, compared to $1.63 billion in the prior year's second quarter. This decrease was primarily driven by market factors, including higher interest credited expenses and lower variable investment income, as well as unfavorable underwriting and other insurance adjustments across several segments, particularly Group Benefits and Asia. Despite the decline in profitability, MetLife's total assets grew to $702.47 billion as of June 30, 2025, up from $677.46 billion at the end of 2024. The company continued its share repurchase program, acquiring approximately $1.92 billion in common stock during the first six months of 2025. MetLife also remains active in managing its capital, with significant repurchase authorizations in place. The company has also announced a pending acquisition of PineBridge Investments, expected to close by the end of 2025, which aims to bolster its investment management capabilities.

MetLife, Inc. (MET) has filed an 8-K Current Report on August 6, 2025, announcing its financial results for the quarter ended June 30, 2025. The report primarily incorporates by reference a series of supplemental documents, including the company's Earnings Release, a Quarterly Financial Supplement, and a Total Assets Under Management (AUM) Fact Sheet. These documents, along with a supplemental slide presentation, provide investors with a comprehensive overview of MetLife's performance and financial condition for the most recent quarter. While the 8-K itself does not contain the detailed financial figures, it directs investors to the attached exhibits for critical information. Investors should review the Earnings Release and Quarterly Financial Supplement for specific metrics such as revenue, net income, earnings per share, and segment performance. The Total AUM Fact Sheet will offer insights into the scale of MetLife's investment management capabilities as of the end of the second quarter.

MetLife, Inc. (MET) has announced a significant executive appointment, naming Adrienne O’Neill as its new Executive Vice President and Chief Accounting Officer, effective September 2, 2025. This appointment brings a seasoned financial executive with extensive experience in accounting, investor relations, and various segments of the financial services industry from her tenure at Manulife Financial Corporation. Investors should note her comprehensive background, which includes roles such as CFO of Asia Segment and Global Controller. Ms. O’Neill's compensation package reflects her seniority and the transition, including a base salary of $525,000, eligibility for discretionary incentive awards, pro-rated for 2025, and substantial sign-on awards totaling $1,950,000 in cash and stock. These sign-on awards are designed to offset forfeited compensation from her previous employer. The report also clarifies that the current interim Chief Accounting Officer, Toby Srihiran Brown, will transition back to his role as Executive Vice President and Global Head of Reinsurance. This filing does not indicate any related-party transactions or arrangements concerning Ms. O’Neill's appointment.

MetLife, Inc. (MET) has announced a significant reinsurance agreement with Chariot Reinsurance, Ltd., aimed at transferring approximately $10 billion of its liabilities. This transaction covers structured settlement annuity contracts and group annuity contracts related to pension risk transfers. The agreement is designed to reduce MetLife's exposure to these specific blocks of business, potentially enhancing its financial flexibility and capital position. Investors should view this as a strategic move to manage risk and optimize its balance sheet by offloading a substantial portion of these long-duration liabilities.

MetLife Inc. (MET) has filed a Form 8-K to provide a preliminary, unaudited estimate of its variable investment income for the quarter ending June 30, 2025. The company anticipates variable investment income to be in the range of $175 million to $225 million (pre-tax). This disclosure is intended to offer early insight into a specific component of their expected financial performance ahead of the official earnings release and quarterly financial supplement scheduled for August 6, 2025. Investors should note that this information is preliminary and has not undergone the full financial closing procedures. Consequently, actual results could differ materially from these estimates. This disclosure is furnished under Regulation FD and is not intended to be a substitute for the comprehensive financial statements that will be filed later in accordance with U.S. GAAP, nor should it be used to infer other financial or operating data. Investors are advised to exercise caution when relying on this preliminary data.

MetLife, Inc. (MET) has filed an 8-K report detailing the outcomes of its annual meeting of common shareholders held on June 17, 2025. The key resolutions passed include the election of eleven directors for terms expiring at the 2026 annual meeting, the ratification of Deloitte & Touche LLP as the company's independent auditor for 2025, and an advisory approval of the compensation for Named Executive Officers. All director nominees received a substantial majority of "For" votes, indicating strong shareholder confidence in the current board. The ratification of the auditor and the advisory vote on executive compensation also saw significant shareholder approval, with "For" votes outnumbering "Against" votes by a wide margin in both cases. These results suggest a stable governance framework and continued shareholder support for the company's leadership and its chosen auditors. The "Broker Non-Votes" noted in the director elections represent shares held by brokers where the beneficial owner did not provide voting instructions. While these do not count for or against a proposal, their presence is standard in many shareholder meetings and does not appear to have impacted the decisive outcomes for the director elections or other proposals. Investors can view these outcomes as a positive sign of established corporate governance practices at MetLife.

MetLife Inc. (MET) has announced the issuance of ¥87.84 billion (approximately $790 million USD as of June 2025, based on typical exchange rates) in yen-denominated senior notes through a private placement. This offering consists of six tranches with varying maturities ranging from 2032 to 2055 and coupon rates between 2.14% and 3.62%. The proceeds are earmarked for refinancing existing debt, specifically ¥25.2 billion of senior notes maturing in 2026, and for general corporate purposes. This transaction diversifies MetLife's funding sources and potentially extends its debt maturity profile. The issuance in a foreign currency indicates a strategic move to manage currency exposures or access international capital markets. While the notes are not registered under the Securities Act, they were offered in reliance on an exemption for private placements, a common practice for large corporate debt issuances. Investors should note that these are senior unsecured obligations of MetLife, Inc.

MetLife, Inc. (MET) has filed an 8-K report detailing the declaration of its quarterly preferred stock dividends. This filing, dated May 14, 2025, and announced on May 15, 2025, confirms ongoing dividend payments for three series of preferred stock, including Series A (floating rate), Series E (5.625%), and Series F (4.75%). For investors holding these preferred securities, the key takeaway is the continued commitment to distributing dividends as per the established terms. The specific dividend amounts per share have been clearly outlined for each series, providing transparency for shareholders regarding their expected income from these preferred stock holdings. The filing itself primarily serves as a formal announcement and does not contain new financial performance data, but rather confirms a routine financial action.

MetLife, Inc. (MET) reported a solid first quarter for 2025, with net income attributable to common shareholders of $879 million, an increase from $800 million in the prior year's first quarter. Adjusted earnings available to common shareholders remained stable at $1.3 billion year-over-year, demonstrating resilience in its core operations despite some market headwinds. Total revenues saw a significant increase to $18.6 billion, driven primarily by a substantial rise in premiums and a favorable shift in net derivative gains (losses), which more than offset a decrease in net investment income. The company continues to execute its strategic initiatives, including the pending acquisition of PineBridge Investments, which is expected to close in the second half of 2025, bolstering its asset management capabilities. Total assets grew to $677.5 billion from $688.3 billion, reflecting a solid investment portfolio. Total liabilities also increased, but equity remained relatively stable. The company's robust capital position, supported by strong adjusted earnings and careful liquidity management, positions it well to navigate the evolving economic landscape and pursue strategic growth opportunities. Investors should note the significant favorable change in net derivative gains, which significantly boosted net income, highlighting the impact of market volatility on reported earnings.

MetLife, Inc. has filed an 8-K report detailing its financial and operational updates for the quarter ended March 31, 2025. The report includes the release of its earnings, a quarterly financial supplement, and a fact sheet on assets under management (AUM). These documents provide a comprehensive view of the company's performance and financial position during the period. Key investor information includes the announcement of a new $3.0 billion stock repurchase authorization by the Board of Directors, signaling a commitment to returning capital to shareholders. While the specific financial results for the quarter are detailed in the furnished exhibits, this 8-K serves as the official notification and provides access to the detailed financial reporting, including AUM figures and supplemental slides for further analysis.

MetLife, Inc. (MET) has announced a significant strategic move through a reinsurance agreement with Talcott Resolution Life Insurance Company, effective April 30, 2025. This agreement involves reinsuring approximately $10 billion of U.S. retail variable annuity and rider reserves. This transaction is designed to de-risk MetLife's balance sheet by reducing its exposure to these long-duration liabilities. Investors should view this as a step towards enhancing capital efficiency and potentially improving financial flexibility as the company shifts its focus and capital allocation strategies.

MetLife, Inc. (MET) has filed an 8-K report on March 27, 2025, primarily announcing the resignation of director David L. Herzog. Mr. Herzog will step down from the Board of Directors effective May 1, 2025, and will not seek re-election at the upcoming annual meeting. Importantly, the company has stated that Mr. Herzog's decision is not due to any disagreements regarding the Company's operations, policies, or practices. This event is considered routine and does not appear to signal any significant underlying issues with the company's governance or business operations at this time. Investors should monitor future board composition and any potential strategic implications arising from changes in board membership.

MetLife Inc. (MET) has filed an 8-K report detailing the issuance of $1 billion in 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055. This issuance was conducted under the company's existing shelf registration statement and a related prospectus supplement, with the transaction finalized on March 13, 2025. The purpose of this issuance is to raise capital, likely to bolster its financial flexibility and support its ongoing business operations. A significant event accompanying this debt issuance is the termination of the company's Replacement Capital Covenants. These covenants, originally established in connection with earlier debt issuances, were tied to specific "covered debt." The newly issued debentures now qualify as "covered debt," and the holders of these new debentures have consented to the termination of the prior covenants. This action simplifies MetLife's debt structure and removes past obligations associated with these covenants.

MetLife Inc. (MET) filed an 8-K on March 5, 2025, primarily to confirm the previously announced declaration of its first quarter 2025 dividend for its floating rate non-cumulative preferred stock, Series A. This dividend is set at $0.35516415 per share, with a liquidation preference of $25 per share. The filing serves as an official record of this distribution, providing clarity to preferred stockholders regarding their upcoming payment. While this filing does not contain new financial results or significant operational updates, it reinforces MetLife's commitment to returning capital to its shareholders through regular dividend payments on its preferred stock. Investors holding this specific series of preferred stock can expect the declared dividend to be paid as scheduled. The news release attached as an exhibit further details this declaration.

MetLife Inc. (MET) has announced the completion of a private placement of $1.25 billion in Pre-Capitalized Trust Securities (P-Caps) maturing in 2055. These P-Caps serve as a contingent funding arrangement, providing MetLife with the right to issue up to $1.25 billion in 5.740% Senior Notes due 2055 to the Trust over a thirty-year period. The proceeds from the P-Cap issuance were invested by the Trust in U.S. Treasury securities, effectively securing the future obligation. This transaction establishes a forward-looking financing mechanism that strengthens MetLife's capital structure and provides a predetermined cost of capital for future debt issuance. While the P-Caps are restricted to qualified institutional buyers, the arrangement itself offers MetLife flexibility in managing its long-term liabilities and interest rate exposure. The company will pay a semi-annual facility fee on the unexercised portion of the Issuance Right, with specific triggers for automatic or mandatory exercise of the Senior Notes issuance.

MetLife Inc. (MET) announced a change in its Chief Accounting Officer role and an expansion of its Board of Directors in a recent 8-K filing. Effective March 15, 2025, Toby Srihiran Brown will assume the interim Chief Accounting Officer (CAO) position, succeeding Tamara L. Schock who previously indicated her intent to resign. Mr. Brown brings extensive experience within MetLife, having held various senior finance and operational roles, including his current position as Executive Vice President and Global Head of Reinsurance. This transition is part of an ongoing search for a permanent CAO. Furthermore, the Board of Directors has been expanded to fourteen members with the appointment of Christian Mumenthaler, effective May 1, 2025. Mr. Mumenthaler, who has been deemed an independent director, will serve on the Finance and Risk Committee and the Investment Committee. He will be compensated under the standard non-management director compensation plan, which includes a combination of stock and cash.

MetLife Inc.'s 2024 Form 10-K highlights a business operating within a complex and dynamic economic landscape. The report emphasizes forward-looking statements, cautioning investors that actual results may differ materially from projections due to a multitude of risks and uncertainties. These risks are broad-ranging, encompassing economic downturns, fluctuating interest rates, credit market adversity, and potential downgrades in financial strength ratings. Additionally, the company faces operational challenges, including reinsurance availability, regulatory changes, litigation, cybersecurity threats, and the successful integration of any future acquisitions or reorganizations.

MetLife Inc. (MET) has filed an 8-K report detailing the declaration of several preferred stock dividends, as announced in a news release dated February 18, 2025. This filing is primarily focused on returning capital to preferred shareholders, indicating the company's ongoing commitment to its dividend policies. Investors should note the specific dividend amounts and frequencies for various preferred stock series, which provide a degree of income predictability for holders of these securities. While this report primarily concerns dividend declarations, it's important for common shareholders to understand how these preferred dividends impact overall financial flexibility and potential distributions to common stock. The declaration suggests MetLife is in a position to meet its preferred dividend obligations, which is a positive indicator of financial stability. Investors should monitor any further announcements regarding common stock dividends or share repurchases in conjunction with these preferred dividend declarations.

MetLife, Inc. (MET) has filed an 8-K report on February 5, 2025, detailing its financial results for the fourth quarter and full year ended December 31, 2024, alongside its strategic outlook for 2025 and beyond. The report includes the company's earnings release, a quarterly financial supplement, and an asset under management fact sheet. A key takeaway for investors is the company's "New Frontier" five-year strategy, designed to accelerate growth and deliver attractive, all-weather returns, building on the success of its prior "Next Horizon" strategy. The company's outlook for 2025 anticipates continued economic uncertainties, including inflation and unemployment, and a strengthening U.S. dollar. Despite these challenges, MetLife projects stable long-term interest rates with a steepening yield curve as short-term rates decline, and it expresses confidence in its diversified investment portfolio's ability to perform across various economic scenarios. Furthermore, MetLife highlighted its strong liquidity position, exceeding its holding company cash target, and its ongoing commitment to returning capital to shareholders, with significant free cash flow generation expected over the next five years.

MetLife Inc. (MET) announced the upcoming resignation of Tamara L. Schock, Executive Vice President and Chief Accounting Officer, effective on or about March 14, 2025. Ms. Schock's departure is attributed to personal reasons and is not a result of any disagreements with the company regarding its financial reporting, internal controls, operations, or policies. This change in a key financial leadership role may warrant investor attention as the company navigates its succession planning and ensures a smooth transition in its accounting oversight. While the report does not disclose any immediate financial impacts or strategic shifts stemming from this departure, investors should monitor future communications from MetLife for updates on the appointment of a successor and any potential effects on the company's financial reporting processes. The filing confirms that the resignation is not indicative of any underlying issues with the company's financial statements or internal controls.

MetLife, Inc. has filed an 8-K report to announce its upcoming Investor Day on December 12, 2024, where the company will unveil its "New Frontier" growth strategy and outline long-term financial commitments. This strategic initiative signals a forward-looking approach to business development and capital allocation, which investors will want to closely monitor for potential impacts on future performance and shareholder returns. The accompanying press release and presentation slides, furnished as exhibits to this filing, provide the core details of this new strategy. Investors should pay close attention to the specifics of the New Frontier strategy, including any new market focus, product innovations, or operational efficiencies MetLife intends to pursue. The long-term financial commitments will be particularly important in understanding the company's expected trajectory regarding profitability, capital deployment, and potentially dividend or share repurchase policies. This event represents a key opportunity for investors to gain deeper insights into MetLife's strategic direction and its implications for the company's competitive positioning and financial health.

MetLife, Inc. (MET) announced on December 11, 2024, the anticipated launch of Chariot Reinsurance, Ltd. ("Chariot Re"), a new third-party offshore reinsurance company. This venture, developed in partnership with General Atlantic, will leverage MetLife Investment Management and General Atlantic as asset managers, with both entities making minority equity investments in Chariot Re. MetLife has secured conditional approval from the Bermuda Monetary Authority for registration in Bermuda, indicating significant progress towards the launch targeted for the first half of 2025, pending regulatory approvals and other closing conditions. This strategic initiative involves MetLife initially ceding approximately $10 billion of statutory reserves related to structured settlement and group annuity contracts from pension risk transfers to Chariot Re. The company anticipates this transaction will result in an estimated increase of approximately $1 billion in available capital. Investors should view this as a move to enhance capital efficiency and potentially de-risk a portion of its balance sheet by transferring specific annuity liabilities to a new reinsurance entity.

MetLife, Inc. (MET) filed an 8-K report on November 15, 2024, primarily announcing the declaration of quarterly dividends on its preferred stock. This filing serves as an update for investors regarding the company's commitment to returning capital through dividend distributions. The company declared dividends for three series of preferred stock: Series A (floating rate non-cumulative), Series E (5.625% non-cumulative), and Series F (4.75% non-cumulative). The specific dividend amounts per share for each series were detailed, providing clarity on the expected payouts to preferred stockholders. This action underscores MetLife's ongoing financial stability and its strategy to reward its investors.

MetLife Inc. reported strong financial results for the nine months ended September 30, 2024, with net income available to common shareholders increasing significantly to $2.99 billion from $806 million in the prior year period. This growth was driven by a substantial improvement in net investment gains and a favorable shift in net derivative gains (losses), partially offset by unfavorable market risk benefit remeasurement (gains) losses and higher income tax expenses. Adjusted earnings available to common shareholders also showed resilience, increasing to $4.34 billion from $4.16 billion year-over-year, reflecting strong underlying business performance across most segments, although impacted by a reinsurance transaction and market factors. The company's total assets grew to $704.98 billion from $687.58 billion at the end of 2023, supported by growth in investments and policyholder account balances. Total liabilities also increased, primarily driven by higher future policy benefits and policyholder account balances. MetLife continues to execute its capital management strategy, with share repurchases totaling $2.8 billion for the nine-month period, demonstrating a commitment to returning capital to shareholders. The company maintains a strong liquidity position, with $21.77 billion in cash and cash equivalents as of September 30, 2024.

MetLife Inc. (MET) filed an 8-K on October 30, 2024, to announce its financial results for the quarter ended September 30, 2024. The filing includes a press release detailing the company's operational and financial performance, a supplemental quarterly financial report, and a fact sheet on assets under management (AUM). This report is crucial for investors seeking to understand MetLife's recent financial standing and operational highlights. While the 8-K itself does not contain detailed financial figures, it directs investors to accompanying exhibits for comprehensive data. These exhibits provide the earnings release, a detailed quarterly financial supplement, and information on total assets under management as of the end of the third quarter. Additionally, a supplemental slide presentation offers further insights and context to the reported results, aiding investors in their analysis of MetLife's performance and strategic positioning.

MetLife Inc. (MET) filed an 8-K on September 29, 2024, detailing the issuance of an additional $250 million in 5.300% Senior Notes due 2034. This issuance, which occurred on September 30, 2024, was conducted under the Company's existing shelf registration statement and supplements a prior issuance of the same notes. The primary purpose of this filing is to report a new direct financial obligation. Investors should note that this $250 million debt issuance increases the Company's overall leverage. The fixed interest rate of 5.300% on these notes will contribute to ongoing interest expenses. The full terms and conditions of these notes and the related indentures are incorporated by reference into this filing.

MetLife Inc. (MET) filed an 8-K on August 15, 2024, primarily to announce the declaration of various preferred stock dividends. The report details the payment of quarterly dividends for Series A, Series E, and Series F preferred stock, as well as semi-annual dividends for Series D and Series G preferred stock. This announcement is routine for the company and provides clarity on upcoming distributions to preferred shareholders. For common shareholders, this filing does not contain information regarding common stock dividends or material business updates. Investors should view this 8-K as a standard operational disclosure concerning MetLife's commitment to its preferred stockholders, with no immediate implications for the company's overall financial performance or strategic direction indicated in this specific report. The details provided are for informational purposes regarding dividend payouts on specific preferred stock series.

MetLife, Inc. reported solid financial results for the second quarter of 2024. Net income available to common shareholders significantly improved to $912 million, up from $370 million in the prior year period, and adjusted earnings available to common shareholders increased to $1.63 billion from $1.49 billion. This performance was driven by favorable underwriting and other insurance adjustments across segments, particularly in Group Benefits, and improved investment income, including higher returns on private equity and fixed income securities. The company also benefited from volume growth in several segments, notably in its international operations. However, a higher effective tax rate and the impact of a reinsurance transaction in MetLife Holdings partially offset these gains. The company's balance sheet remains robust, with total assets of $675.7 billion. Despite a decrease in total investments to $436.8 billion from $446.1 billion at year-end 2023, the company's liquidity position remains strong, with $20.8 billion in cash and cash equivalents. MetLife continues to actively manage its capital, returning value to shareholders through share repurchases and dividends, while navigating a dynamic economic environment characterized by fluctuating interest rates and global economic conditions.

MetLife Inc. (MET) filed an 8-K report on July 31, 2024, primarily announcing its financial results for the quarter ended June 30, 2024. The filing incorporates by reference a news release (Exhibit 99.1), a Quarterly Financial Supplement (Exhibit 99.2), and a Total Assets Under Management (AUM) Fact Sheet (Exhibit 99.3). These documents provide detailed operational and financial condition information for the period. The company also furnished a supplemental slide presentation (Exhibit 99.4) to highlight key information from these reports and prior disclosures.

MetLife Inc. (MET) filed an 8-K on June 24, 2024, detailing key outcomes from its annual shareholder meeting on June 18, 2024. The most significant developments for investors revolve around the approval of new long-term and annual incentive compensation plans. Shareholders overwhelmingly approved the MetLife, Inc. 2025 Stock and Incentive Compensation Plan, which will govern equity-based awards to employees and directors starting January 1, 2025. Additionally, the Board of Directors approved the MetLife Annual Variable Incentive Plan (AVIP) for performance periods commencing on or after January 1, 2025, which will provide for annual cash incentive awards based on established criteria. Beyond compensation plan updates, the meeting saw the election of thirteen Directors to serve until the 2025 annual meeting. The appointment of Deloitte & Touche LLP as the independent auditor for 2024 was ratified. Shareholders also provided an advisory vote of approval for the compensation paid to Named Executive Officers. Notably, a shareholder proposal requesting a third-party racial equity audit was not approved.

MetLife Inc. (MET) has filed an 8-K report announcing the issuance of $500 million in Senior Notes due in 2034, carrying a coupon rate of 5.300%. This debt issuance was conducted under the company's existing shelf registration statement and a related prospectus supplement. The proceeds from these notes are expected to be used for general corporate purposes. This move indicates MetLife's active management of its capital structure and its ability to access public debt markets. Investors should note that the issuance of new debt increases the company's leverage. The specific use of proceeds for general corporate purposes suggests flexibility in how the company plans to deploy these funds, which could include operational needs, strategic investments, or refinancing existing obligations. The long-term nature of these notes (10-year maturity) implies a strategic approach to funding.

MetLife, Inc. (MET) filed an 8-K report on May 15, 2024, primarily announcing the declaration of quarterly dividends on its preferred stock. This filing confirms the continuation of dividend payments for its Series A, Series E, and Series F preferred stock. For investors holding these specific preferred securities, this report provides confirmation of their upcoming dividend payouts. While this 8-K is limited in scope and does not contain material updates on the company's overall financial performance or strategic initiatives, it signals MetLife's ongoing commitment to returning capital to its shareholders through regular dividend distributions. Investors should note that these dividends pertain to preferred stock and are distinct from any common stock dividends the company may issue.

MetLife Inc. reported a strong first quarter for 2024, demonstrating significant year-over-year improvement in key financial metrics. Net income available to common shareholders surged to $800 million, a substantial increase from $14 million in the prior year's first quarter. This growth was driven by a favorable shift in net investment gains and a significant reduction in net derivative losses, alongside improved market conditions impacting market risk benefit remeasurements. Adjusted earnings also saw a healthy increase to $1.33 billion, up from $1.18 billion in Q1 2023, reflecting underlying business performance and favorable market factors. The company maintained a strong capital position and continued its share repurchase program, repurchasing over $1.17 billion in common stock during the quarter. Total assets stood at $677.6 billion at the end of the quarter, with total liabilities of $648.8 billion, resulting in total equity of $28.8 billion. The company's diversified business segments, including Group Benefits, RIS, Asia, Latin America, EMEA, and MetLife Holdings, collectively contributed to this performance, with notable strength observed in the Asia and Latin America segments, driven by volume growth and favorable market conditions, partially offset by foreign currency fluctuations. Looking ahead, MetLife's strategic focus on managing its investment portfolio for long-term value and its robust capital management strategy are expected to support continued financial performance. The company's ability to navigate evolving economic conditions and regulatory landscapes, as evidenced by this quarter's results, positions it well for sustained shareholder value creation. Investors should monitor the company's ongoing progress in its strategic initiatives, its response to market interest rate movements, and its international segment performance.

MetLife Inc. (MET) filed an 8-K on May 1, 2024, reporting its first-quarter 2024 results. The filing primarily includes earnings releases, a quarterly financial supplement, and a fact sheet detailing assets under management as of March 31, 2024. While the specific financial figures for the quarter are not detailed within the 8-K itself, these accompanying documents provide the comprehensive results investors will need to assess the company's performance. Investors should review these exhibits for detailed financial performance metrics and operational updates for the period.

MetLife Inc. announced on March 12, 2024, its intention to redeem all outstanding 5.375% Senior Notes due December 9, 2024. This redemption, totaling £350 million in principal, is scheduled for April 11, 2024, and is being executed in accordance with the terms of the notes. Investors holding these specific notes should be aware of this early repayment. The company has provided this information through a news release, which is attached to the 8-K filing. While this filing serves as an announcement, it is important to note that it does not constitute the official notice of redemption itself. Shareholders and noteholders should refer to official notices for definitive details regarding the redemption process.

MetLife Inc. (MET) filed an 8-K report on March 6, 2024, detailing the issuance of a significant aggregate principal amount of senior notes denominated in Japanese Yen (¥) on March 7, 2024. This issuance includes seven tranches of senior notes with varying maturity dates ranging from 2029 to 2059 and fixed interest rates from 1.009% to 2.448%. The notes were registered under a shelf registration statement and offered through a prospectus supplement, indicating that MetLife is actively managing its capital structure and likely diversifying its funding sources. This debt issuance represents a strategic move by MetLife to secure long-term funding at what appear to be relatively favorable fixed rates, especially considering the current interest rate environment. Investors should view this as a proactive capital management activity. The substantial amount raised suggests potential uses such as refinancing existing debt, funding new initiatives, or bolstering its financial flexibility. The specific terms and denominations in JPY may indicate efforts to match assets and liabilities in that currency or to tap into specific investor bases.